\BOOKMARK [0][]{chapter*.6}{Motivation and Objectives}{}% 1
\BOOKMARK [-1][]{part.1}{I State of the art}{}% 2
\BOOKMARK [0][]{chapter.1}{Parameter Estimation}{part.1}% 3
\BOOKMARK [1][]{section.1.1}{Optimization and Intervals}{chapter.1}% 4
\BOOKMARK [1][]{section.1.2}{Optimizing Identifiability}{chapter.1}% 5
\BOOKMARK [2][]{subsection.1.2.1}{Methods based on FIM}{section.1.2}% 6
\BOOKMARK [2][]{subsection.1.2.2}{Monte-Carlo methods}{section.1.2}% 7
\BOOKMARK [2][]{subsection.1.2.3}{Practical Identifiability and Optimality}{section.1.2}% 8
\BOOKMARK [1][]{section.1.3}{Identification with Uncertainty}{chapter.1}% 9
\BOOKMARK [2][]{subsection.1.3.1}{Error-bounded Estimation}{section.1.3}% 10
\BOOKMARK [1][]{section.1.4}{Software and optimization tools}{chapter.1}% 11
\BOOKMARK [2][]{subsection.1.4.1}{Scatter search for Matlab}{section.1.4}% 12
\BOOKMARK [2][]{subsection.1.4.2}{Covariance Matrix Adaptive Estimation}{section.1.4}% 13
\BOOKMARK [2][]{subsection.1.4.3}{- MOGA Evolutionary Algorithm}{section.1.4}% 14
\BOOKMARK [0][]{chapter.2}{Models for the artificial pancreas development}{part.1}% 15
\BOOKMARK [1][]{section.2.1}{Introduction}{chapter.2}% 16
\BOOKMARK [1][]{section.2.2}{Insulin absorption models}{chapter.2}% 17
\BOOKMARK [2][]{subsection.2.2.1}{UVA model}{section.2.2}% 18
\BOOKMARK [2][]{subsection.2.2.2}{Cambridge model}{section.2.2}% 19
\BOOKMARK [1][]{section.2.3}{Glucose absorption models}{chapter.2}% 20
\BOOKMARK [2][]{subsection.2.3.1}{UVA model}{section.2.3}% 21
\BOOKMARK [2][]{subsection.2.3.2}{Cambridge model}{section.2.3}% 22
\BOOKMARK [1][]{section.2.4}{Endogenous models}{chapter.2}% 23
\BOOKMARK [2][]{subsection.2.4.1}{Bergman model}{section.2.4}% 24
\BOOKMARK [2][]{subsection.2.4.2}{Panunzi model}{section.2.4}% 25
\BOOKMARK [2][]{subsection.2.4.3}{UVA model}{section.2.4}% 26
\BOOKMARK [2][]{subsection.2.4.4}{Cambridge model}{section.2.4}% 27
\BOOKMARK [1][]{section.2.5}{Critical selection of models}{chapter.2}% 28
\BOOKMARK [0][]{chapter.3}{Identification in Diabetes}{part.1}% 29
\BOOKMARK [1][]{section.3.1}{Patient Identification}{chapter.3}% 30
\BOOKMARK [1][]{section.3.2}{Experiment Design for Artificial Pancreas}{chapter.3}% 31
\BOOKMARK [1][]{section.3.3}{Uncertainty and Interval Identification in Diabetes}{chapter.3}% 32
\BOOKMARK [0][]{chapter*.15}{Conclusions}{part.1}% 33
\BOOKMARK [-1][]{part.2}{II Issues in Continuous Glucose Monitoring for Patient Identification}{}% 34
\BOOKMARK [0][]{chapter.4}{Optimal Experiment Design}{part.2}% 35
\BOOKMARK [1][]{section.4.1}{Introduction}{chapter.4}% 36
\BOOKMARK [1][]{section.4.2}{Experiments designed with Bergman's model}{chapter.4}% 37
\BOOKMARK [1][]{section.4.3}{Experiments designed with modified Panunzi's model}{chapter.4}% 38
\BOOKMARK [1][]{section.4.4}{Discussion and clinical protocol}{chapter.4}% 39
\BOOKMARK [0][]{chapter.5}{CGM Statistical Modeling and Validation}{part.2}% 40
\BOOKMARK [1][]{section.5.1}{Data and methodology}{chapter.5}% 41
\BOOKMARK [1][]{section.5.2}{CGM Modelling}{chapter.5}% 42
\BOOKMARK [2][]{subsection.5.2.1}{Analysis of delay}{section.5.2}% 43
\BOOKMARK [2][]{subsection.5.2.2}{Analysis of Stationarity}{section.5.2}% 44
\BOOKMARK [2][]{subsection.5.2.3}{Distribution fitting}{section.5.2}% 45
\BOOKMARK [1][]{section.5.3}{Validation}{chapter.5}% 46
\BOOKMARK [0][]{chapter*.16}{Conclusions}{part.2}% 47
\BOOKMARK [-1][]{part.3}{III Interval identification}{}% 48
\BOOKMARK [0][]{chapter.6}{A New Paradigm for Model Individualization in T1DM}{part.3}% 49
\BOOKMARK [1][]{section.6.1}{Optimization Set-up}{chapter.6}% 50
\BOOKMARK [1][]{section.6.2}{Identification from reference glucose}{chapter.6}% 51
\BOOKMARK [1][]{section.6.3}{Identification from CGM}{chapter.6}% 52
\BOOKMARK [1][]{section.6.4}{Discussion}{chapter.6}% 53
\BOOKMARK [0][]{chapter.7}{Identification From in-Patient Reference Data}{part.3}% 54
\BOOKMARK [1][]{section.7.1}{Optimization and index definition}{chapter.7}% 55
\BOOKMARK [1][]{section.7.2}{Validation Results}{chapter.7}% 56
\BOOKMARK [1][]{section.7.3}{Best-case permutation}{chapter.7}% 57
\BOOKMARK [1][]{section.7.4}{Discussion}{chapter.7}% 58
\BOOKMARK [0][]{chapter.8}{Identification Under Domiciliary Conditions}{part.3}% 59
\BOOKMARK [1][]{section.8.1}{Optimization settings and parameters}{chapter.8}% 60
\BOOKMARK [1][]{section.8.2}{Influence of the Lack of Plasma Insulin Measurements}{chapter.8}% 61
\BOOKMARK [1][]{section.8.3}{Identification from CGM data}{chapter.8}% 62
\BOOKMARK [1][]{section.8.4}{Discussion}{chapter.8}% 63
\BOOKMARK [0][]{chapter*.17}{Conclusions}{part.3}% 64
\BOOKMARK [-1][]{future.-1}{Final conclusions and future work}{}% 65
\BOOKMARK [0][]{chapter.9}{Final conclusions and future work}{future.-1}% 66
